Clinical Trials Logo
NCT number NCT03302611
Study type Interventional
Source United States Naval Medical Center, San Diego
Contact Betty Michalewicz-Kragh, M.S.
Phone 619-532-7727
Email betty.michalewiczkragh.civ@mail.mil
Status Not yet recruiting
Phase N/A
Start date January 2018
Completion date September 2020

Clinical Trial Summary

This study uses a randomized controlled trial design to compare the psychological effects of surf therapy to hike therapy in active duty service members who have been diagnosed with major depressive disorder.


Clinical Trial Description

This prospective, longitudinal randomized controlled trial will enroll up to 86 active duty service members with major depressive disorder who are seeking surf or hike therapy as part of their standard medical care. Participants will be randomly assigned to receive 6 weeks of either surf or hike therapy. Assessor-administered and self-report measures will be completed at pre- and post-program, as well as three months following program completion. Participants also will complete brief, self-report assessments before and after each program activity session.


Study Design


Related Conditions & MeSH terms


See also
  Status Clinical Trial Phase
Active, not recruiting NCT02192099 - Open Label Extension for GLYX13-C-202, NCT01684163 Phase 2
Recruiting NCT03307070 - Adapted Cognitive Behavioral Treatment for Depression in Patients With Moderate to Severe Traumatic Brain Injury N/A
Recruiting NCT03113890 - McLean and Genomind Prospective Study N/A
Not yet recruiting NCT02948036 - A Closed-loop Assessment and Treatment Platform for Mood Disorders N/A
Recruiting NCT02939560 - TMS for Adults With Autism and Depression N/A
Recruiting NCT02674529 - Study of Neural Responses Induced by Antidepressant Effects Phase 2/Phase 3
Active, not recruiting NCT02934035 - Early Improvement in Individual Symptoms and Response to Antidepressants in Patients With Major Depressive Disorder N/A
Active, not recruiting NCT02855580 - Integrating Pharmacogenomic Testing Into a Child Psychiatry Clinic N/A
Not yet recruiting NCT02766920 - Augmentation of Treatment-Resistant Depression With An Analog of the Neuroactive Steroid Allopregnanolone N/A
Not yet recruiting NCT02871141 - Multimodal Imaging of ECT Effects N/A
Completed NCT02309060 - Storytelling Video Intervention for Depressed Primary Care Patients - Open Trial N/A
Recruiting NCT03088657 - Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study N/A
Recruiting NCT02922556 - Piloting a Novel, Mobile Cognitive Training Tool for Patients With Major Depressive Disorder (MDD) N/A
Recruiting NCT02624102 - Efficacy of Trial-Based Cognitive Therapy and Behavioral Activation in Treatment of Depression Phase 3
Recruiting NCT02530164 - Transcranial Direct Current Stimulation (tDCS) As Treatment for Major Depression N/A
Terminated NCT01613820 - Ketamine and Scopolamine Infusions for Treatment-resistant Major Depressive Disorder N/A
Not yet recruiting NCT02502604 - Cognitive Training Program for Individuals With Depression and Post-Traumatic Stress Disorder N/A
Recruiting NCT02078817 - Ketamine in Adolescents With Treatment-Resistant Depression Phase 2
Recruiting NCT03265340 - Clinical Effect of dTMS in Major Depressive Disorder N/A
Active, not recruiting NCT01787240 - Neurobiological Bases of Placebo Response in Major Depressive Disorder Phase 4